Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cucchetti

Showing results (221-230 of 301) with videos related to

Pageof 31
Sort By:
World Journal of Gastroenterology|October 2, 2018
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?Giorgia Marisi, Alessandro Cucchetti, Paola Ulivi, et al.
Annals of Surgery|December 4, 2023
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 PatientsStefano Crippa, Giuseppe Malleo, Serena Langella, et al.
Transplantation|June 14, 2008
Incidence and management of abdominal closure-related complications in adult intestinal transplantationChiara Zanfi, Matteo Cescon, Augusto Lauro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2019
Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of DecompensationIndra Neil Guha, Rebecca Harris, Sarah Berhane, et al.
European Radiology|June 12, 2021
Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinomaIlaria Vicentin, Cristina Mosconi, Enrico Garanzini, et al.
The Oncologist|November 16, 2013
Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II studyGiovanni Brandi, Francesco de Rosa, Valentina Agostini, et al.
Transplantation|March 11, 2015
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled TrialMatteo Ravaioli, Flavia Neri, Tiziana Lazzarotto, et al.
Journal of Hepatology|October 27, 2011
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor poolElisabetta Loggi, Lorenzo Micco, Giorgio Ercolani, et al.
British Journal of Cancer|February 22, 2023
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?Alessandro Cucchetti, Omar Elshaarawy, Guohong Han, et al.
JAMA Surgery|July 24, 2024
Futility of Up-Front Resection for Anatomically Resectable Pancreatic CancerStefano Crippa, Giuseppe Malleo, Vincenzo Mazzaferro, et al.
Pageof 31

Showing results (221-230 of 301) with videos related to

Sort By:
Pageof 31
World Journal of Gastroenterology|October 2, 2018
Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?Giorgia Marisi, Alessandro Cucchetti, Paola Ulivi, et al.
Annals of Surgery|December 4, 2023
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 PatientsStefano Crippa, Giuseppe Malleo, Serena Langella, et al.
Transplantation|June 14, 2008
Incidence and management of abdominal closure-related complications in adult intestinal transplantationChiara Zanfi, Matteo Cescon, Augusto Lauro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2019
Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of DecompensationIndra Neil Guha, Rebecca Harris, Sarah Berhane, et al.
European Radiology|June 12, 2021
Inter-center agreement of mRECIST in transplanted patients for hepatocellular carcinomaIlaria Vicentin, Cristina Mosconi, Enrico Garanzini, et al.
The Oncologist|November 16, 2013
Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II studyGiovanni Brandi, Francesco de Rosa, Valentina Agostini, et al.
Transplantation|March 11, 2015
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled TrialMatteo Ravaioli, Flavia Neri, Tiziana Lazzarotto, et al.
Journal of Hepatology|October 27, 2011
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor poolElisabetta Loggi, Lorenzo Micco, Giorgio Ercolani, et al.
British Journal of Cancer|February 22, 2023
'Potentially curative therapies' for hepatocellular carcinoma: how many patients can actually be cured?Alessandro Cucchetti, Omar Elshaarawy, Guohong Han, et al.
JAMA Surgery|July 24, 2024
Futility of Up-Front Resection for Anatomically Resectable Pancreatic CancerStefano Crippa, Giuseppe Malleo, Vincenzo Mazzaferro, et al.
Pageof 31